Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Sci Adv 6:eaay9751 Hamilton EP, Ma C, De Laurentiis M, Iwata H, Hurvitz SA, Wander SA et al (2024) VERITAC-2: a phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2-advanced breast cancer
Women with hormonal imbalances should consult healthcare providers before starting treatment
Glia 65:12051226 Abbott NJ, Romero IA (1996) Transporting therapeutics across the blood-brain barrier
To view a copy of this licence, visit About this article Cite this article Baker, P.R., Li, A.S., Griffin, B.R
Supplied as sterile bacteriostatic water intended for laboratory handling and peptide reconstitution research
Ready to Take the First Step
US$ 23.57
US$ 23.72
US$ 24.52
US$ 23.32
